Effectum CH-REP
Effectum CH-REP AG is a Swiss regulatory services firm that acts as the legally required Swiss Authorized Representative (CH-REP) for non-Swiss medical device manufacturers seeking Swiss market access under MedDO and EU MDR/IVDR, providing PRRC, ISO 13485 QMS, and legal manufacturer services on an annual mandate basis.
- Company typePrivate
- Founded2017
- HeadquartersOlten, Switzerland
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Effectum CH-REP does
Effectum CH-REP AG is a Swiss regulatory services firm that acts as the legally required Swiss Authorized Representative (CH-REP, Schweizer Bevollmächtigter) for medical device manufacturers based outside Switzerland. The company is a brand under the parent entity QUNIQUE AG (CHE-230.350.138, headquartered at Bahnhofweg 17, Wohlen), with operational contact at Kirchgasse 11, Olten. Founded in 2017, the firm was structured to address the regulatory gap created by the May 26, 2021 entry into force of the Swiss Medical Devices Ordinance (MedDO SR 812.213), which mandates that non-Swiss manufacturers not covered by a third-country or mutual recognition agreement appoint a CH-REP in order to sell into Switzerland.
Its core offering combines four integrated capabilities: (1) CH-REP legal representation, including registration with Swissmedic, incident and complaint reporting, and guaranteed access to technical documentation; (2) provision of an in-house Person Responsible for Regulatory Compliance (PRRC) as required under EU MDR; (3) outsourced quality management systems aligned with ISO 13485; and (4) technical documentation review. Notably, Effectum also acts as legal manufacturer (rechtlicher Hersteller) on behalf of clients, jointly assuming product liability risk and requiring inclusion in the client's liability insurance — a structural differentiator from pure-representative competitors. Services cover medical device Classes I through III and IVD Classes A through D, with Class III / IVD Class D mandates accepted only in exceptional cases after detailed review.
The business operates a sales-led, quote-based go-to-market targeting a single customer segment (non-Swiss medical device manufacturers) within a single geography (Switzerland/DACH). Pricing is annual subscription-based and varies by number of technical documentations, EMDN/GMDN/UMDNS codes, and product risk class. Distribution is direct, driven by a structured four-step process (offer, NDA, technical documentation review, contract signing) initiated through the firm's website inquiry form. The firm has 11–50 employees, is privately held, has no disclosed funding, and shows no M&A, partnership, or public-market activity in the source data.
Effectum CH-REP firmographics
Firmographics- Name
- Effectum CH-REP
- Legal name
- QUNIQUE AG
- Website
- https://effectum-chrep.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Effectum CH-REP AG is a Swiss regulatory services firm that acts as the legally required Swiss Authorized Representative (CH-REP) for non-Swiss medical device manufacturers seeking Swiss market access under MedDO and EU MDR/IVDR, providing PRRC, ISO 13485 QMS, and legal manufacturer services on an annual mandate basis.
- Ownership category
- akta.pro rank
Effectum CH-REP industry classification
Industry- Product category
- Medical Device Regulatory Services
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA) (HLAGAKAA)
Keywords
Where Effectum CH-REP is headquartered
LocationHeadquarters
- HQ city
- Olten
- HQ country
- Switzerland
- HQ region
- Europe
Offices2 records
Markets served
Effectum CH-REP business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Swiss Bevollmächtigter (CH-REP) Mandate Services: Fees charged for acting as Swiss Authorized Representative for medical device manufacturers. The company jointly assumes risk as legal manufacturer and provides PRRC, technical documentation access, Swissmedic cooperation, incident reporting, and compliance monitoring services. Pricing is quote-based, dependent on number of technical documentations and product risk classes (I, IIa, IIb, III, A-D for IVDs).
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Custom quote based on product portfolio complexity |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Effectum CH-REP product offering
Product offeringCore offering
Effectum CH-REP AG acts as the legally mandated Swiss Authorized Representative (Schweizer Bevollmächtigter / CH-REP) for non-Swiss medical device and in-vitro diagnostic (IVD) manufacturers, enabling them to legally place products on the Swiss market under MedDO SR 812.213. Services include provision of an in-house PRRC, outsourced ISO 13485 quality management systems, technical documentation review, Swissmedic registration, vigilance and incident reporting, post-market surveillance, and shared legal-manufacturer risk assumption with liability insurance coverage.
Product overview
Effectum CH-REP AG provides a unified regulatory services offering centered on Swiss Authorized Representative (CH-REP) services for medical device manufacturers outside Switzerland. As a single integrated service, they offer outsourced quality management systems (ISO 13485), technical documentation review, and act as legal manufacturer with shared risk responsibility. The company also provides a Person Responsible for Regulatory Compliance (PRRC), handles Swissmedic registrations, and manages incident/complaint reporting for Class I through III medical devices and IVD products (Classes A through D).
Differentiator
Problem solved
Functional benefit
Products and services
- Swiss Authorized Representative (CH-REP) Services Legal representation services for non-Swiss medical device and IVD manufacturers, acting as the required Schweizer Bevollmächtigter to enable market access in Switzerland under MedDO and EU MDR/IVDR frameworks. Includes PRRC provision, Swissmedic registration, incident and complaint reporting, vigilance, and guaranteed access to technical documentation copies.
- Outsourced Quality Management Systems (ISO 13485) Externalized quality management system services for medical devices built and maintained according to ISO 13485 standards, bundled with the CH-REP mandate to ensure continuous compliance across the product lifecycle.
- Technical Documentation Review Verification and review of complete technical documentation for medical devices and IVDs to confirm compliance with Swiss regulatory requirements and EU MDR/IVDR alignment prior to market entry.
- Legal Manufacturer Services with Liability Coverage Effectum CH-REP AG assumes the role of legal manufacturer (rechtlicher Hersteller) on behalf of clients, sharing product liability risk and maintaining comprehensive liability insurance coverage as part of the mandate.
Companies that use Effectum CH-REP
Customer profileSegments1 record
Ideal customer profiles1 record
Effectum CH-REP technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Effectum CH-REP partnerships and signals
Strategic signalScale indicators2 records
Recent moves5 records
Expansion highlights4 records
Effectum CH-REP competitors and assessment
Company assessmentDirect peers
- Medidee Services: Swiss-headquartered medical device regulatory affairs and quality compliance consulting firm offering CH-REP, EU AR, ISO 13485 QMS, and clinical evaluation services. Closest direct competitor given shared Swiss base, full-service regulatory mandate portfolio, and target customer overlap with non-Swiss manufacturers seeking market access.
- Qserve Group: Netherlands-based medical device regulatory consulting firm providing EU AR services, regulatory strategy, clinical evaluation, and ISO 13485 QMS support. Directly comparable business model focused on regulatory representation for non-EU manufacturers, though operating across EU rather than Switzerland specifically.
- Medical Device Safety Service (MDSS): Germany-based regulatory service provider specializing in EU Authorized Representative mandates for non-EU medical device manufacturers under MDR/IVDR. Directly comparable service offering and customer base, focused exclusively on regulatory representation services similar to Effectum's CH-REP model.
- Johner Institute: German-speaking medical device regulatory and quality compliance consultancy providing EU AR, technical documentation, and ISO 13485 services to manufacturers. Comparable business model, target customer segment, and DACH regional overlap make it a meaningful peer for cross-border mandate opportunities.
Broad incumbents
- Emergo by UL: Global regulatory affairs and quality assurance consulting firm acquired by UL, offering EU AR, CH-REP, and broader market access services across medical devices and IVDs. Significantly larger than Effectum with broader geographic footprint, but overlaps materially in the medical device regulatory representation niche.
- TÜV SÜD Product Service: Large global testing, inspection, and certification body offering notified body services, ISO 13485 certification, and regulatory consulting for medical devices. While far broader in scope, TÜV SÜD competes for adjacent services and is a potential partner or competitor in the Swiss regulatory services market.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Effectum CH-REP compliance and trust
Trust signalCompliance2 records
Effectum CH-REP financial estimates
Financial estimateRevenue estimate
Valuation estimate
Effectum CH-REP leadership team
Management profileNumber of profiles
Effectum CH-REP funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Effectum CH-REP M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Effectum CH-REP
What does Effectum CH-REP do?
Effectum CH-REP AG acts as the legally mandated Swiss Authorized Representative (Schweizer Bevollmächtigter / CH-REP) for non-Swiss medical device and in-vitro diagnostic (IVD) manufacturers, enabling them to legally place products on the Swiss market under MedDO SR 812.213. Services include provision of an in-house PRRC, outsourced ISO 13485 quality management systems, technical documentation review, Swissmedic registration, vigilance and incident reporting, post-market surveillance, and shared legal-manufacturer risk assumption with liability insurance coverage.
Is Effectum CH-REP a public or private company?
Effectum CH-REP is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Effectum CH-REP founded?
Effectum CH-REP was founded in 2017. It employs 11 to 50 people.
Where is Effectum CH-REP based?
Effectum CH-REP is headquartered in Olten, Switzerland, in the Europe region.
How does Effectum CH-REP make money?
One revenue line is on record: swiss Bevollmächtigter (CH-REP) Mandate Services.
Who are Effectum CH-REP's main competitors?
Direct peers on record are Medidee Services, Qserve Group, Medical Device Safety Service (MDSS) and Johner Institute. Broad incumbents are Emergo by UL and TÜV SÜD Product Service.
Does Effectum CH-REP have an API?
No public API is recorded for Effectum CH-REP.
What industry is Effectum CH-REP in?
Effectum CH-REP's product category is Medical Device Regulatory Services. Its primary akta.pro industry code is HLAGAKAA, Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA). Its NAICS code is 5417 and its SIC code is 8731.